Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 3 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

33%

1 of 3 completed trials have results

Key Signals

1 with results

Enrollment Performance

Analytics

Phase 2
1(50.0%)
N/A
1(50.0%)
2Total
Phase 2(1)
N/A(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (3)

Showing 3 of 3 trials
NCT05155176Completed

Novel Real-world Methods in Social Drinkers and AUD

Role: collaborator

NCT02785406Phase 2Completed

Role of the Orexin Receptor System in Stress, Sleep and Cocaine Use

Role: collaborator

NCT02492893Not ApplicableCompleted

Yoga Intervention for Substance Use and ART Adherence in Community Reentry

Role: collaborator

All 3 trials loaded